Fenofibrate - redOrbit

News - Fenofibrate

Stopping Statin Therapy Increases Risk Of Death For Rheumatoid Arthritis Patients

2012-03-28 17:28:59

Patients with rheumatoid arthritis (RA) who discontinue use of statin therapy are at increased risk of death from cardiovascular disease and other causes.

Stopping Statin Therapy Increases Risk Of Death For Rheumatoid Arthritis Patients

2012-03-28 17:28:59

Patients with rheumatoid arthritis (RA) who discontinue use of statin therapy are at increased risk of death from cardiovascular disease and other causes.

Phase 2b Trial Shows Unique Lipid Efficacy Profile of Novel Compound to Reduce Elevated Triglyceride Levels

2012-02-29 07:00:00

SAN DIEGO, Feb.

Veloxis Pharmaceuticals A/S and Athena Drug Delivery Solutions Pvt. Ltd. Announce Partnership to Develop, Manufacture and Commercialize Its Investigational Drug Atorfen(TM) (Fenofibrate-Atorvastin Fixed Dose Combination) in Certain Emerging Markets

2011-12-22 23:01:00

HORSHOLM, Denmark, Dec. 23, 2011 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) and Athena Drug Delivery Solutions Pvt. Ltd.

Omthera Pharmaceuticals, Inc. Initiates Phase III ESPRIT Trial of Add-on Epanova(TM) to Statin Therapy in Patients with Hypertriglyceridemia

2011-08-15 08:14:00

BEDMINSTER, N.J., Aug.

More News (98 articles) »